Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-09-13 Sale |
2023-09-25 8:31 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
5,617 | $48.32 | $271,416 | 71,182 (Direct) |
View |
| 2023-09-13 Sale |
2023-09-25 8:30 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
531 | $50.34 | $26,731 | 150,689 (Direct) |
View |
| 2023-09-13 Sale |
2023-09-25 8:28 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
562 | $50.34 | $28,291 | 243,177 (Indirect Direct) |
View |
| 2023-09-01 Sale |
2023-09-18 6:48 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
25,000 | $49.77 | $1,244,248 | 527,680 (Direct) |
View |
| 2023-08-28 Sale |
2023-08-30 7:04 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
5,745 | $49.99 | $287,191 | 76,799 (Direct) |
View |
| 2023-08-08 Purchase |
2023-08-10 4:46 pm |
Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director |
25,000 | $42.06 | $1,051,475 | 602,168 (Indirect Direct) |
View |
| 2023-08-01 Sale |
2023-08-03 4:13 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
25,000 | $43.15 | $1,078,867 | 537,680 (Direct) |
View |
| 2023-07-28 Purchase |
2023-08-01 7:52 pm |
Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director |
55,000 | $42.95 | $2,362,234 | 577,168 (Indirect Direct) |
View |
| 2023-07-03 Sale |
2023-07-06 8:44 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
25,000 | $44.88 | $1,122,041 | 562,680 (Direct) |
View |
| 2023-06-21 Sale |
2023-06-23 8:06 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
33,349 | $51.74 | $1,725,390 | 46,627 (Direct) |
View |
| 2023-06-20 Sale |
2023-06-22 5:20 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
20,777 | $55 | $1,142,735 | 243,429 (Direct) |
View |
| 2023-06-16 Sale |
2023-06-21 5:54 pm |
Akero Therapeutics Inc. | AKRO | Heyman Tomas J. Director |
26,000 | $54.67 | $1,421,529 | 0 (Direct) |
View |
| 2023-06-16 Sale |
2023-06-21 5:47 pm |
Akero Therapeutics Inc. | AKRO | Henderson Jane Director |
40,000 | $54.17 | $2,166,685 | 14,797 (Direct) |
View |
| 2023-06-16 Sale |
2023-06-21 5:46 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
78,200 | $54.78 | $4,284,066 | 154,016 (Direct) |
View |
| 2023-06-13 Sale |
2023-06-15 9:41 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
606 | $55.16 | $33,427 | 22,377 (Direct) |
View |
| 2023-06-13 Sale |
2023-06-15 9:38 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
1,613 | $55.16 | $88,973 | 407,680 (Direct) |
View |
| 2023-06-13 Sale |
2023-06-15 9:35 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
509 | $55.16 | $28,076 | 189,420 (Direct) |
View |
| 2023-06-13 Sale |
2023-06-15 9:35 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
538 | $55.16 | $29,676 | 243,739 (Indirect Direct) |
View |
| 2023-06-13 Sale |
2023-06-15 9:29 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
591 | $55.16 | $32,600 | 79,976 (Direct) |
View |
| 2022-09-19 Purchase(A) |
2023-06-15 9:26 pm |
Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director |
520,000 | $29.69 | $15,440,000 | 522,168 (Indirect Direct) |
View |
| 2023-06-01 Sale |
2023-06-05 6:23 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
25,000 | $45.1 | $1,127,430 | 613,831 (Direct) |
View |
| 2023-05-19 Purchase |
2023-05-23 9:55 pm |
Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director |
520,000 | $29.69 | $15,440,000 | 522,168 (Indirect Direct) |
View |
| 2023-05-01 Sale |
2023-05-03 8:28 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
25,000 | $45.07 | $1,126,860 | 652,373 (Direct) |
View |
| 2023-04-03 Sale |
2023-04-05 4:55 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
25,000 | $37.94 | $948,576 | 480,161 (Direct) |
View |
| 2023-03-01 Sale |
2023-03-03 4:21 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
25,000 | $46.65 | $1,166,338 | 506,867 (Direct) |
View |
| 2023-02-01 Sale |
2023-02-03 5:25 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
25,000 | $49.06 | $1,226,395 | 531,867 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-09-21 Exercise |
2023-09-25 8:31 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
5,000 | $6.36 | 71,182 (Direct) |
View |
| 2023-09-21 Exercise |
2023-09-25 8:31 pm |
N/A 2029-01-15 |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
5,000 | $0 | 71,182 (Direct) |
View |
| 2023-09-01 Exercise |
2023-09-18 6:48 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
25,000 | $6.36 | 527,680 (Direct) |
View |
| 2023-09-01 Exercise |
2023-09-18 6:48 pm |
N/A 2029-01-15 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
25,000 | $0 | 527,680 (Direct) |
View |
| 2023-08-30 Exercise |
2023-08-30 7:04 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
15,000 | $0.615 | 564,892 (Direct) |
View |
| 2023-08-30 Exercise |
2023-08-30 7:04 pm |
N/A 2028-09-07 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
15,000 | $0 | 564,892 (Direct) |
View |
| 2023-08-28 Exercise |
2023-08-30 7:04 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
5,745 | $6.36 | 76,799 (Direct) |
View |
| 2023-08-28 Exercise |
2023-08-30 7:04 pm |
N/A 2029-01-15 |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
5,745 | $0 | 76,799 (Direct) |
View |
| 2023-08-01 Exercise |
2023-08-03 4:13 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
25,000 | $6.36 | 537,680 (Direct) |
View |
| 2023-08-01 Exercise |
2023-08-03 4:13 pm |
N/A 2029-01-15 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
25,000 | $0 | 537,680 (Direct) |
View |
| 2023-07-03 Exercise |
2023-07-06 8:44 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
25,000 | $6.36 | 562,680 (Direct) |
View |
| 2023-07-03 Exercise |
2023-07-06 8:44 pm |
N/A 2029-01-15 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
25,000 | $0 | 562,680 (Direct) |
View |
| 2023-06-27 Exercise |
2023-06-27 7:12 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
40,000 | $0.615 | 564,892 (Direct) |
View |
| 2023-06-27 Exercise |
2023-06-27 7:12 pm |
N/A 2028-09-07 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
40,000 | $0 | 564,892 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-27 6:00 pm |
N/A 2033-06-22 |
Akero Therapeutics Inc. | AKRO | Xu Yuan Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-27 5:58 pm |
N/A 2033-06-22 |
Akero Therapeutics Inc. | AKRO | Judy Chou Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-27 5:55 pm |
N/A 2033-06-22 |
Akero Therapeutics Inc. | AKRO | Henderson Jane Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-27 5:52 pm |
N/A 2033-06-22 |
Akero Therapeutics Inc. | AKRO | Heyman Tomas J. Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-27 5:48 pm |
N/A 2033-06-22 |
Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-27 5:48 pm |
N/A 2033-06-22 |
Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-27 5:39 pm |
N/A 2033-06-22 |
Akero Therapeutics Inc. | AKRO | Iwicki Mark T Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-06-20 Exercise |
2023-06-22 5:20 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
17,500 | $7.009 | 243,429 (Direct) |
View |
| 2023-06-20 Exercise |
2023-06-22 5:20 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
17,500 | $0 | 243,429 (Direct) |
View |
| 2023-06-16 Exercise |
2023-06-21 5:54 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Heyman Tomas J. Director |
26,000 | $25.04 | 0 (Direct) |
View |
| 2023-06-16 Exercise |
2023-06-21 5:54 pm |
N/A 2030-06-09 |
Akero Therapeutics Inc. | AKRO | Heyman Tomas J. Director |
26,000 | $0 | 0 (Direct) |
View |
| 2023-06-16 Exercise |
2023-06-21 5:47 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Henderson Jane Director |
40,000 | $7.01 | 14,797 (Direct) |
View |
| 2023-06-16 Exercise |
2023-06-21 5:47 pm |
N/A 2029-04-02 |
Akero Therapeutics Inc. | AKRO | Henderson Jane Director |
40,000 | $0 | 14,797 (Direct) |
View |
| 2023-06-16 Exercise |
2023-06-21 5:46 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
40,000 | $0.61 | 154,016 (Direct) |
View |
| 2023-06-16 Exercise |
2023-06-21 5:46 pm |
N/A 2028-07-29 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
40,000 | $0 | 154,016 (Direct) |
View |
| 2023-06-01 Exercise |
2023-06-05 6:23 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
21,330 | $0.615 | 613,831 (Direct) |
View |
| 2023-06-01 Exercise |
2023-06-05 6:23 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
3,670 | $6.36 | 613,831 (Direct) |
View |
| 2023-06-01 Exercise |
2023-06-05 6:23 pm |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
25,000 | $0 | 613,831 (Direct) |
View |
| 2023-04-18 Exercise |
2023-05-03 8:28 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
65,000 | $0.615 | 652,373 (Direct) |
View |
| 2023-04-18 Exercise |
2023-05-03 8:28 pm |
N/A 2028-09-07 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
65,000 | $0 | 652,373 (Direct) |
View |
| 2023-04-03 Exercise |
2023-04-05 4:55 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
25,000 | $0.615 | 480,161 (Direct) |
View |
| 2023-04-03 Exercise |
2023-04-05 4:55 pm |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
25,000 | $0 | 480,161 (Direct) |
View |
| 2023-03-10 Tax Withholding |
2023-03-14 4:25 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
641 | $43.47 | 22,983 (Direct) |
View |
| 2023-03-10 Tax Withholding |
2023-03-14 4:20 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
701 | $43.46 | 80,567 (Direct) |
View |
| 2023-03-10 Tax Withholding |
2023-03-14 4:19 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
634 | $43.47 | 244,277 (Direct) |
View |
| 2023-03-10 Tax Withholding |
2023-03-14 4:19 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
603 | $43.47 | 189,929 (Direct) |
View |
| 2023-03-10 Tax Withholding |
2023-03-14 4:18 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
1,706 | $43.47 | 369,293 (Direct) |
View |
| 2023-03-01 Exercise |
2023-03-03 4:21 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
25,000 | $0.615 | 506,867 (Direct) |
View |
| 2023-03-01 Exercise |
2023-03-03 4:21 pm |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
25,000 | $0 | 506,867 (Direct) |
View |
| 2023-02-01 Exercise |
2023-02-03 5:25 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
25,000 | $0.615 | 531,867 (Direct) |
View |
| 2023-02-01 Exercise |
2023-02-03 5:25 pm |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
25,000 | $0 | 531,867 (Direct) |
View |